project id: TCGA-LGG; case submitter id: TCGA-P5-A5EU; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 8.8; age at index: 35; days to birth: -12851; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1977; age at diagnosis: 12851; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 0.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9401/3; primary diagnosis: Astrocytoma, anaplastic; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 86; initial weight: 500.0; sample id: 1a82630e-d49e-4e33-8768-1167de6b5f97; sample submitter id: TCGA-P5-A5EU-01A; portion id: 4b26c473-8d79-47fa-9d43-51f89f7bdbb2; portion submitter id: TCGA-P5-A5EU-01A-11; slide id: 68b6098d-7964-4aa0-a7ff-a6c511bf31c5; slide submitter id: TCGA-P5-A5EU-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 45.0; percent tumor cells: 50.0; percent tumor nuclei: 80.0; section location: TOP;